Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 4,514,929 | +4,514,929 | 0 | 45,827 | 9.93% | +45,827 |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | 50,482 | 70,025 | 15.18% | +19,543 |
| CRISPR Therapeutics AG(CRSP) | 1,048,951 | 1,048,951 | 0 | 35,696 | 51,021 | 11.06% | +15,325 |
| Zenas BioPharma, Inc(ZBIO) | 4,911,539 | 4,911,539 | 0 | 38,801 | 47,593 | 10.32% | +8,792 |
| Arcellx, Inc. COMMON STOCK | 2,346,630 | 2,346,630 | 0 | 153,939 | 154,526 | 33.49% | +587 |
| Oruka Therapeutics, Inc(ORKA) | 430,330 | 430,330 | 0 | 4,415 | 4,824 | 1.05% | +409 |
| Oculis Holding AG(OCS) | 322,500 | 322,500 | 0 | 6,137 | 6,260 | 1.36% | +123 |
| KALA Bio, Inc.(KALA) | 598,940 | 598,940 | 0 | 3,432 | 2,851 | 0.62% | -581 |
| Nkarta, Inc.(NKTX) | 3,333,333 | 3,333,333 | 0 | 6,133 | 5,533 | 1.20% | -600 |
| enGene Holdings Inc. COM | 747,750 | 747,750 | 0 | 3,350 | 2,722 | 0.59% | -628 |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | 25,192 | 21,994 | 4.77% | -3,198 |
| Alumis Inc. | 1,959,896 | 1,959,896 | 0 | 12,034 | 5,880 | 1.27% | -6,154 |
| Mineralys Therapeutics Inc.(MLYS) | 3,127,933 | 3,127,933 | 0 | 49,672 | 42,321 | 9.17% | -7,351 |